145
Views
4
CrossRef citations to date
0
Altmetric
Article

Transurethral resection of the prostate: fate of the non-responders

ORCID Icon, ORCID Icon &
Pages 443-448 | Received 12 Mar 2020, Accepted 06 Aug 2020, Published online: 04 Sep 2020

References

  • Statistikdatabas för operationer i slutenvård: Socialstyrelsen; 2018; [cited 2019 Dec 17]. Available from: http://www.socialstyrelsen.se.
  • Sagen E, Hedelin H, Nelzén O, et al. Defining and discriminating responders from non-responders following transurethral resection of the prostate. Scand J Urol. 2018;52(5–6):437–444.
  • Sagen E, Namnuan RO, Hedelin H, et al. The morbidity associated with a TURP procedure in routine clinical practice, as graded by the modified Clavien-Dindo system. Scand J Urol. 2019;53(4):240–245.
  • Thomas AW, Cannon A, Bartlett E, et al. The natural history of lower urinary tract dysfunction in men: Minimum 10-year urodynamic followup of transurethral resection of prostate for bladder outlet obstruction. J Urol. 2005;174(5):1887–1891.
  • Reich O, Gratzke C, Bachmann A, et al. Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10,654 patients. J Urol. 2008;180(1):246–249.
  • Tasc AI, Ilbey YO, Tugcu V, et al. Transurethral resection of the prostate with monopolar resectoscope: single-surgeon experience and long-term results of after 3589 procedures. Urology. 2011;78(5):1151–1155.
  • Ahyai SA, Gilling P, Kaplan SA, et al. Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement. Eur Urol. 2010;58(3):384–397.
  • Hakenberg OW, Pinnock CB, Marshall VR. The follow-up of patients with unfavourable early results of transurethral prostatectomy. BJU Int. 1999;84(7):799–804.
  • Seaman EK, Jacobs BZ, Blaivas JG, et al. Persistence or recurrence of symptoms after transurethral resection of the prostate: a urodynamic assessment. J Urol. 1994;152(3):935–937.
  • Mamoulakis C, Efthimiou I, Kazoulis S, et al. The modified Clavien classification system: a standardized platform for reporting complications in transurethral resection of the prostate. World J Urol. 2011;29(2):205–210.
  • Godartad prostataförstoring med avflödeshinder: en systematisk litteraturöversikt. Stockholm: Statens beredning för medicinsk utvärdering (SBU); 2011. Swedish.
  • de Wildt MJAM, Tubaro A, Hofner K, et al. Responders and nonresponders to transurethral microwave thermotherapy: a multicenter retrospective analysis. J Urol. 1995;154(5):1775–1778.
  • Logadottir Y, Dahlstrand C, Fall M, et al. Invasive urodynamic studies are well tolerated by the patients and associated with a low risk of urinary tract infection. Scand J Urol Nephrol. 2001;35(6):459–462.
  • Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology of lower urinary tract function: report from the standardisation sub-committee of the international continence society. Neurourol Urodyn. 2002;21(2):167–178.
  • Thomas AW, Cannon A, Bartlett E, et al. The natural history of lower urinary tract dysfunction in men: the influence of detrusor underactivity on the outcome after transurethral resection of the prostate with a minimum 10-year urodynamic follow-up. BJU Int. 2004;93(6):745–750.
  • Ghalayini IF, Al-Ghazo MA, Pickard RS. A prospective randomized trial comparing transurethral prostatic resection and clean intermittent self-catheterization in men with chronic urinary retention. BJU Int. 2005;96(1):93–97.
  • Uren AD, Drake MJ. Definition and symptoms of underactive bladder. Investig Clin Urol. 2017;58(Suppl 2):S61–S67.
  • Osman NI, Chapple CR, Abrams P, et al. Detrusor underactivity and the underactive bladder: a new clinical entity? A review of current terminology, definitions, epidemiology, aetiology, and diagnosis. Eur Urol. 2014;65(2):389–398.
  • Blatt AH, Brammah S, Tse V, et al. Transurethral prostate resection in patients with hypocontractile detrusor-what is the predictive value of ultrastructural detrusor changes? J Urol. 2012;188(6):2294–2299.
  • Drake MJ, Williams J, Bijos DA. Voiding dysfunction due to detrusor underactivity: an overview. Nat Rev Urol. 2014;11(8):454–464.
  • Kim M, Jeong CW, Oh SJ. Effect of preoperative urodynamic detrusor underactivity on transurethral surgery for benign prostatic hyperplasia: a systematic review and meta-analysis. J Urol. 2018;199(1):237–244.
  • Machino R, Kakizaki H, Ameda K, et al. Detrusor instability with equivocal obstruction: a predictor of unfavorable symptomatic outcomes after transurethral prostatectomy. Neurourol Urodyn. 2002;21(5):444–449.
  • Ou R, Pan C, Chen H, et al. Urodynamically diagnosed detrusor hypocontractility: should transurethral resection of the prostate be contraindicated? Int Urol Nephrol. 2012;44(1):35–39.
  • Metcalfe C, Poon KS. Long-term results of surgical techniques and procedures in men with benign prostatic hyperplasia. Curr Urol Rep. 2011;12(4):265–273.
  • Wasson JH, Reda DJ, Bruskewitz RC, et al. A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. N Engl J Med. 1995;332(2):75–79.
  • Kuo HC. Analysis of the pathophysiology of lower urinary tract symptoms in patients after prostatectomy. Urol Int. 2002;68(2):99–104.
  • Zhang P, Gao J, Wu Z. Urodynamic analysis of non-improvement after prostatectomy. Chin Med J. 2002;115(7):1093–1095.
  • Doll HA, Black NA, McPherson K. Transurethral resection of the prostate for benign prostatic hypertrophy: factors associated with a successful outcome at 1 year. Br J Urol. 1994;73(6):669–680.
  • Roehrborn CG. Focus on lower urinary tract symptoms: nomenclature, diagnosis, and treatment options: highlights from the 5th international consultation on benign prostatic hyperplasia June 25–27, 2000, Paris, France. Rev Urol. 2001;3(3):139–145.
  • Drake MJ. The integrative physiology of the bladder. Ann R Coll Surg Engl. 2007;89(6):580–585.
  • Oelke M, Bachmann A, Descazeaud A, et al. EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol. 2013;64(1):118–140.
  • McVary KT, Roehrborn CG, Avins AL, et al. Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol. 2011;185(5):1793–1803.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.